Analysis Article • 17h
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedMay 24, 2026
DataAggregated Company Financials
Companies326
- 7D0.3%
- 3M9.9%
- 1Y9.4%
- YTD8.0%
Over the last 7 days, the Healthcare industry has remained flat, although notably Gland Pharma gained 25%. As for the the longer term, the industry is up 9.4% over the past 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 24 May 2026 | ₹32.9t | ₹6.1t | ₹802.9b | 30.6x | 41x | 5.4x |
| Tue, 21 Apr 2026 | ₹30.3t | ₹5.9t | ₹780.6b | 30.5x | 38.8x | 5.1x |
| Thu, 19 Mar 2026 | ₹29.7t | ₹5.9t | ₹780.6b | 27.6x | 38x | 5x |
| Sat, 14 Feb 2026 | ₹29.7t | ₹5.9t | ₹778.4b | 29.1x | 38.1x | 5x |
| Mon, 12 Jan 2026 | ₹30.3t | ₹5.7t | ₹771.5b | 32.2x | 39.2x | 5.3x |
| Wed, 10 Dec 2025 | ₹30.1t | ₹5.7t | ₹768.0b | 33.6x | 39.2x | 5.3x |
| Fri, 07 Nov 2025 | ₹30.5t | ₹5.6t | ₹740.5b | 34.6x | 41.2x | 5.5x |
| Sun, 05 Oct 2025 | ₹30.0t | ₹5.5t | ₹730.3b | 34.6x | 41x | 5.5x |
| Tue, 02 Sep 2025 | ₹30.0t | ₹5.5t | ₹730.0b | 35.2x | 41.1x | 5.5x |
| Thu, 31 Jul 2025 | ₹31.5t | ₹5.4t | ₹732.0b | 37.6x | 43x | 5.9x |
| Sat, 28 Jun 2025 | ₹29.8t | ₹5.3t | ₹728.5b | 35.7x | 41x | 5.6x |
| Mon, 26 May 2025 | ₹28.8t | ₹5.3t | ₹722.6b | 35x | 39.9x | 5.4x |
| Wed, 23 Apr 2025 | ₹28.4t | ₹5.2t | ₹680.2b | 33.9x | 41.8x | 5.5x |
| Fri, 21 Mar 2025 | ₹28.0t | ₹5.2t | ₹680.1b | 31.4x | 41.1x | 5.4x |
| Sun, 16 Feb 2025 | ₹26.9t | ₹5.2t | ₹681.5b | 31.8x | 39.5x | 5.2x |
| Tue, 14 Jan 2025 | ₹28.4t | ₹5.0t | ₹648.1b | 37.6x | 43.8x | 5.6x |
| Thu, 12 Dec 2024 | ₹29.2t | ₹5.0t | ₹643.1b | 38x | 45.3x | 5.8x |
| Sat, 09 Nov 2024 | ₹28.9t | ₹5.0t | ₹625.9b | 40.9x | 46.2x | 5.8x |
| Mon, 07 Oct 2024 | ₹28.9t | ₹4.9t | ₹605.3b | 43.1x | 47.8x | 5.9x |
| Wed, 04 Sep 2024 | ₹28.5t | ₹4.9t | ₹605.1b | 40.7x | 47.1x | 5.9x |
| Fri, 02 Aug 2024 | ₹26.8t | ₹4.7t | ₹564.4b | 38.7x | 47.4x | 5.6x |
| Sun, 30 Jun 2024 | ₹24.1t | ₹4.6t | ₹548.6b | 36x | 44x | 5.2x |
| Tue, 28 May 2024 | ₹23.2t | ₹4.7t | ₹544.9b | 34.4x | 42.6x | 4.9x |
| Thu, 25 Apr 2024 | ₹22.8t | ₹4.6t | ₹512.8b | 35.4x | 44.5x | 5x |
| Sat, 23 Mar 2024 | ₹22.5t | ₹4.6t | ₹512.5b | 33.5x | 43.8x | 4.9x |
| Mon, 19 Feb 2024 | ₹23.1t | ₹4.6t | ₹511.9b | 35.9x | 45.2x | 5x |
| Wed, 17 Jan 2024 | ₹21.3t | ₹4.4t | ₹477.0b | 36.9x | 44.6x | 4.8x |
| Fri, 15 Dec 2023 | ₹19.6t | ₹4.4t | ₹476.2b | 32.9x | 41.2x | 4.4x |
| Sun, 12 Nov 2023 | ₹18.7t | ₹4.4t | ₹474.4b | 32x | 39.4x | 4.3x |
| Tue, 10 Oct 2023 | ₹18.0t | ₹4.3t | ₹452.1b | 32.3x | 39.8x | 4.2x |
| Thu, 07 Sep 2023 | ₹18.1t | ₹4.2t | ₹450.8b | 32.5x | 40.2x | 4.3x |
| Sat, 05 Aug 2023 | ₹17.7t | ₹4.1t | ₹438.8b | 31.4x | 40.4x | 4.3x |
| Mon, 03 Jul 2023 | ₹16.4t | ₹4.1t | ₹425.6b | 28.6x | 38.5x | 4x |
| Wed, 31 May 2023 | ₹14.9t | ₹4.1t | ₹432.7b | 27.6x | 34.3x | 3.6x |
Price to Earnings Ratio
34.3x
Current Industry PE
- Investors are relatively neutral on the Indian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 41.9x.
- The industry is trading close to its 3-year average PS ratio of 5.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | 0.48% | |
| Healthcare | 0.27% | |
| Medical Equipment | 6.57% | |
| Life Sciences | 1.60% | |
| Healthcare Services | 0.58% | |
| Biotech | 0.33% | |
| Pharma | -0.068% | |
| Healthtech | -0.39% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 64.3x.
- Analysts are expecting annual earnings growth of 47.6%, which is lower than the prior year's growth of 80.4% per year.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 36.5x.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 48% over the next 5 years.
- However this is lower than its past earnings growth rate of 80% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAND Gland Pharma | ₹2.33k | 24.9% +₹76.7b | 52.7% | PE37.4x | |
| APOLLOHOSP Apollo Hospitals Enterprise | ₹8.36k | 3.5% +₹40.3b | 18.4% | PE61.9x | |
| DIVISLAB Divi's Laboratories | ₹6.89k | 1.9% +₹33.6b | 6.2% | PE73.8x | |
| ZYDUSLIFE Zydus Lifesciences | ₹1.04k | 2.7% +₹27.4b | 14.3% | PE20.7x | |
| 500420 Torrent Pharmaceuticals | ₹4.48k | 1.8% +₹26.4b | 41.3% | PE70.2x |
